{
  "ticker": "HMD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02958631",
  "id": "02958631",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250616",
  "time": "0933",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250616/pdf/06ks3vwtchdqw8.pdf",
  "summary": "### Summary of ASX Announcement:  \n**Type: Strategic Partnership Announcement**  \n\n- **Partnership:** HeraMED collaborates with RMIT University and Digital Health CRC for **AI-driven maternity care research** targeting culturally diverse women.  \n- **Project Value:** **$1.245M** (HeraMED\u2019s cash contribution: **$250K over 18 months**).  \n- **Key Output:** Development of a **commercializable AI predictive model** for pre-term delivery risk assessment (licensed IP with RMIT/DHCRC).  \n- **Commercial Impact:** Potential to enhance **HeraCARE platform\u2019s monetization** via AI tools, subscriptions, and third-party integrations.  \n- **Timeline:** 18-month project starting **Q2 2025**; involves 200 participants.  \n\n**Material Takeaways:**  \n1. **Non-dilutive funding** aligns with HeraMED\u2019s R&D strategy.  \n2. **IP commercialization** opportunity via AI models.  \n3. **Dataset expansion** could improve product applicability and future revenue streams.  \n\n*Omitted:* Operational details, leadership quotes, and partner backgrounds (non-material to valuation).",
  "usage": {
    "prompt_tokens": 2249,
    "completion_tokens": 244,
    "total_tokens": 2493,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-15T23:39:39.505056"
}